New Medicines of 2015
Nucala is a prescription drug used to treat severe asthma in patients age 12 and older. Nucala is approved for patients with a history of severe asthma attacks (exacerbations) while on their current asthma treatment. Nucala can reduce the risk of severe asthma attacks by lowering the levels of eosinophils (a type of white blood cell that contributes to the development of asthma) in the body. This medication is injected once every four weeks by a healthcare professional into the upper arm, thigh or abdomen. Common side effects include pain, redness, swelling, itching or burning at the injection site, and headache, back pain and weakness. Nucala offers patients with severe asthma an additional therapy when current treatments cannot maintain adequate control of their asthma.
Reviewed by:
Review Date:
December 29, 2015Citation:
U.S. Food and Drug Administration, "FDA approves first-of-its-kind product for the treatment of melanoma", 2015 U.S. Food and Drug Administration, "FDA approves Praxbind, the first reversal agent for the anticoagulant Pradaxa", 2015 U.S. Food and Drug Administration, "FDA approves Ninlaro, new oral medication to treat multiple myeloma", 2015 U.S. Food and Drug Administration, "FDA approves new treatment for HIV", 2015 U.S. Food and Drug Administration, "FDA approves Nucala to treat severe asthma", 2015 U.S. Food and Drug Administration, "FDA approves new treatment for advanced pancreatic cancer", 2015 U.S. Food and Drug Administration, "FDA approves first treatment for sexual desire disorder", 2015 U.S. Food and Drug Administration, "FDA approves new drug to treat heart failure", 2015 U.S. Food and Drug Administration, "FDA approves Praluent to treat certain patients with high cholesterol", 2015 U.S. Food and Drug Administration, "FDA approves Corlanor to treat heart failure", 2015 All images appear courtesy of Dreamstime
Last Updated:
December 29, 2015